The Blunt Truth

DECEMBER 26, 2019

Welcome to The Week in Weed’s look back at the news of 2019; whether the year has flown by or seemed to last forever, it’s (almost) over now. Without further ado, here’s a look at the stories that grabbed our attention in 2019. Several northeastern states tried to coordinate their marijuana policies.

Banking 71

Banking Hemp Agriculture Seed-To-Sale 71

Cannabis Law Report

MARCH 10, 2019

By Peter Becker on March 8, 2019. Lawmakers in Olympia are determined that 2019 will be better — Hector Castro, Director of Communications for the Washington State Department of Agriculture recently stated, “It makes sense to assist farmers to get seeds in the ground this season.”. AUTHOR: Peter Becker – Lane Powell.

Hemp 45

Hemp Seed-To-Sale Agriculture DEA 45

Canna Law Blog

JULY 26, 2023

Before the 2018 Farm Bill, only a few states ran limited “research” pilot programs for hemp. The whole thing crashed following the 2019 growing season, and a spate of lawsuits ran through the office. Bad policy and the new cannabinoids markets It always starts with policy. Could that be true? Mini hit list below.

Hemp 85

Hemp DEA THC Policy 85

Veriheal

NOVEMBER 6, 2023

Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Wisconsin Wisconsin has no state medical cannabis program and no licensed medical Marijuana dispensaries. Wyoming Wyoming is among the few states without a medical cannabis program.

Legalization 117

Legalization Recreational THC CBD 117

Canna Law Blog

DECEMBER 4, 2019

The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Presently, the public comment period ends on December 30, 2019 and it is unclear whether the comment period will be extended. 15-day preharvest testing by a DEA registered laboratory. 3% Total THC. Your Comments Matter.

Hemp 72

Hemp DEA CBD THC 72

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

AUGUST 24, 2022

The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. city to do so.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Canna Law Blog

AUGUST 30, 2020

As we wrote back in early 2019, the prohibition on interference ONLY applied to hemp cultivated under the 2018 Farm Bill. To be fair, the USDA did issue an opinion in mid-2019 that stated that states/tribes could not prohibit the interstate transport of hemp produced under the 2014 Farm Bill.

Hemp 98

Hemp Agriculture Extraction THC 98

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Authors Tracy Gallegos and Neville M. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Info

SEPTEMBER 13, 2019

Then in 1905, missionaries in Manila spearheaded an anti-opium campaign , a thinly veiled attempt to expel Chinese immigrants (opium dens had already been banned in parts of the US, not because of public health policies, or clinical research, but because of racist scaremongering about the Chinese). No more Oktoberfest.

DEA 45

DEA Policy Media Programs 45

Canna Law Blog

JANUARY 11, 2022

The issue of enforcement or compliance is probably the biggest one most states face at the policy level. Last year, we noted that “Americans are now 19 times more likely to overdose on drugs and about 5 times more likely to be arrested for drugs than they were the year the DEA was created.” Yet, the illicit market is huge.

Compliance 81

Compliance Compliance State Laws DEA 81

CannaMD

SEPTEMBER 10, 2020

Significantly higher numbers come from the Centers for Disease Control , which in 2019 reported that some 16% of pregnant women aged 18 to 44 years self-reported frequent to daily marijuana use. Results do not differentiate between heavy recreational users and mothers engaged in medical cannabis programs.

Marijuana 59

Marijuana Therapy Data THC 59

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. The Florida Highway Patrol Policy Manual outlines these rights. SHORT ANSWER: Maybe.

Law 126

Law Marijuana Patients Treatment 126

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research.

DEA 74

DEA Research and Development Cultivation Supply Chain 74

Cannabis Law Report

NOVEMBER 2, 2021

While it’s not at the level of the 2019 lung disease outbreak, the potential for serious harm to public health is impossible to ignore, and in many ways, delta-8 is a ticking time bomb that could damage the reputation of the cannabis industry for years to come. Is This Similar to the Vitamin E Acetate Crisis in 2019?

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Veriheal

AUGUST 19, 2022

But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes.

Hemp 52

Hemp DEA Access Cultivation 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana. Lyle Craker, Ph.D., Reddit awarded $82,765.95

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

AUGUST 16, 2019

Through late July, the 2019 Cannabis Crusade saw daily cannabis-related news and a literal state of medical marijuana commotion. On July 11, 2019, a Florida Appellate Court ruled in the highly-publicized Florigrown lawsuit that the state’s vertical integration was unfair and unconstitutional. AUTHOR: Heather Allman.

Marijuana 49

Marijuana Research and Development Seed-To-Sale Education 49

SpeedWeed

APRIL 1, 2021

Her pro-pot policies would take shape in college during the ’90s and early 2000s. Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . In 2019, significant progress came with the inclusion of smokable flower in the program. .

Agriculture 52

Agriculture Policy THC Cannabis 52

SpeedWeed

DECEMBER 28, 2018

Perhaps my new year’s resolution for 2019 will be more rolling, less scrolling! Buzz: Cannabis Equity Programs Expand Opportunities. He qualified for the equity program based on a previous felony conviction, and having lived in a neighborhood disproportionately targeted for cannabis arrests.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Federal Register. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JANUARY 14, 2020

601 , the “Medical Cannabis Research Act of 2019” H.R. 3797 , the “Medical Marijuana Research Act of 2019” H.R. 3884 , the “Marijuana Opportunity Reinvestment and Expungement Act of 2019” or the “MORE Act of 2019” Witnesses. Drug Enforcement Administration.

Clinical Trials 69

Clinical Trials Programs Access DEA 69